BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29925593)

  • 1. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.
    Seren S; Rashed Abouzaid M; Eulenberg-Gustavus C; Hirschfeld J; Nasr Soliman H; Jerke U; N'Guessan K; Dallet-Choisy S; Lesner A; Lauritzen C; Schacher B; Eickholz P; Nagy N; Szell M; Croix C; Viaud-Massuard MC; Al Farraj Aldosari A; Ragunatha S; Ibrahim Mostafa M; Giampieri F; Battino M; Cornillier H; Lorette G; Stephan JL; Goizet C; Pedersen J; Gauthier F; Jenne DE; Marchand-Adam S; Chapple IL; Kettritz R; Korkmaz B
    J Biol Chem; 2018 Aug; 293(32):12415-12428. PubMed ID: 29925593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Cathepsin C in PR3-ANCA Vasculitis.
    Jerke U; Eulenberg-Gustavus C; Rousselle A; Nicklin P; Kreideweiss S; Grundl MA; Eickholz P; Nickles K; Schreiber A; Korkmaz B; Kettritz R
    J Am Soc Nephrol; 2022 May; 33(5):936-947. PubMed ID: 35292437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
    Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
    Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).
    Korkmaz B; Lesner A; Letast S; Mahdi YK; Jourdan ML; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Viaud-Massuard MC; Jenne DE; Gauthier F
    Semin Immunopathol; 2013 Jul; 35(4):411-21. PubMed ID: 23385856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
    Granel J; Korkmaz B; Nouar D; Weiss SAI; Jenne DE; Lemoine R; Hoarau C
    Front Immunol; 2021; 12():571933. PubMed ID: 33679731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.
    Kantari C; Pederzoli-Ribeil M; Amir-Moazami O; Gausson-Dorey V; Moura IC; Lecomte MC; Benhamou M; Witko-Sarsat V
    Blood; 2007 Dec; 110(12):4086-95. PubMed ID: 17712045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors.
    Korkmaz B; Kuhl A; Bayat B; Santoso S; Jenne DE
    J Biol Chem; 2008 Dec; 283(51):35976-82. PubMed ID: 18854317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
    Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
    Front Immunol; 2020; 11():573040. PubMed ID: 33101296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.
    Korkmaz B; Jaillet J; Jourdan ML; Gauthier A; Gauthier F; Attucci S
    J Biol Chem; 2009 Jul; 284(30):19896-902. PubMed ID: 19447886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive and induced forms of membrane-bound proteinase 3 interact with antineutrophil cytoplasmic antibodies and promote immune activation of neutrophils.
    Carla Guarino ; Seren S; Lemoine R; Hummel AM; Margotin JE; El-Benna J; Hoarau C; Specks U; Jenne DE; Korkmaz B
    J Biol Chem; 2023 Apr; 299(4):103072. PubMed ID: 36849007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis.
    Rarok AA; Stegeman CA; Limburg PC; Kallenberg CG
    J Am Soc Nephrol; 2002 Sep; 13(9):2232-8. PubMed ID: 12191967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
    Muller Kobold AC; Kallenberg CG; Tervaert JW
    Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitively disrupting the neutrophil-specific receptor-autoantigen CD177:proteinase 3 membrane complex reduces anti-PR3 antibody-induced neutrophil activation.
    Marino SF; Jerke U; Rolle S; Daumke O; Kettritz R
    J Biol Chem; 2022 Mar; 298(3):101598. PubMed ID: 35063507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool.
    Halbwachs-Mecarelli L; Bessou G; Lesavre P; Lopez S; Witko-Sarsat V
    FEBS Lett; 1995 Oct; 374(1):29-33. PubMed ID: 7589506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
    Korkmaz B; Jenne DE; Gauthier F
    Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis.
    Baslund B; Szpirt W; Eriksson S; Elzouki AN; Wiik A; Wieslander J; Petersen J
    Eur J Clin Invest; 1996 Sep; 26(9):786-92. PubMed ID: 8889441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane proteinase 3 and Wegener's granulomatosis.
    von Vietinghoff S; Schreiber A; Otto B; Choi M; Göbel U; Kettritz R
    Clin Nephrol; 2005 Dec; 64(6):453-9. PubMed ID: 16370159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
    Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
    J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis.
    Jenne DE
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S147-54. PubMed ID: 7952651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.